Incid-MD Tablet contains Levocetirizine 5mg, a potent second-generation antihistamine used primarily for the relief of allergic symptoms. Levocetirizine is the active enantiomer of cetirizine and functions as a selective antagonist of peripheral H1 histamine receptors, thereby inhibiting the effects of histamine released during allergic reactions. This medication is indicated for the treatment of allergic rhinitis, including seasonal and perennial types, as well as chronic idiopathic urticaria characterized by itching and hives. Incid-MD Tablet offers rapid onset of action and sustained symptom control with minimal sedation due to its reduced penetration of the blood-brain barrier. It is well-tolerated and can be administered once daily, enhancing patient compliance. The pharmacokinetic profile of Levocetirizine allows for predictable absorption and elimination, primarily via renal excretion. Dosage adjustments may be necessary in patients with renal impairment. Common adverse effects are generally mild and include headache, dry mouth, and fatigue. Incid-MD Tablet should be used with caution in patients with known hypersensitivity to Levocetirizine or related compounds. It is contraindicated during pregnancy and lactation unless clearly needed. Always consult a healthcare professional before initiating therapy with Incid-MD Tablet.